IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v19y2018i3d10.1007_s10198-017-0896-4.html
   My bibliography  Save this article

The socio-economic impact of work disability due to inflammatory bowel disease in Brazil

Author

Listed:
  • Renata S. B. Fróes

    (Universidade do Estado do Rio de Janeiro
    Instituto Nacional do Seguro Social (INSS))

  • Ana Teresa Pugas Carvalho

    (Universidade do Estado do Rio de Janeiro)

  • Antonio Jose V. Carneiro

    (Universidade Federal do Rio de Janeiro)

  • Adriana Maria Hilu Barros Moreira

    (Instituto Nacional do Seguro Social (INSS))

  • Jessica P. L. Moreira

    (Universidade Federal do Rio de Janeiro)

  • Ronir R. Luiz

    (Universidade Federal do Rio de Janeiro)

  • Heitor S. de Souza

    (Universidade Federal do Rio de Janeiro
    D’Or Institute for Research and Education (IDOR))

Abstract

Background Inflammatory bowel disease (IBD) might have economic and social impacts in Brazil, where its prevalence has increased recently. This study aimed to assess disability due to IBD in the Brazilian population and demographic factors potentially associated with absence from work. Methods Analysis was performed using the computerized Single System of Social Security Benefits Information, with a cross-check for aid pension and disability retirement, for Crohn’s disease (CD) and ulcerative colitis (UC). Additional data were obtained from the platform, including the average values, benefit duration, age, gender and region of the country. Results Temporary disability occurred more frequently with UC, whereas permanent disability was more frequent with CD. Temporary disability affected more younger patients with CD than patients with UC. Temporary work absences due to UC and CD were greater in the South, and the lowest absence rates due to CD were noted in the North and Northeast. Absence from work was longer (extending for nearly a year) in patients with CD compared to those with UC. The rates of temporary and permanent disability were greater among women. Permanent disability rates were higher in the South (UC) and Southeast (CD). The value of benefits paid for IBD represented approximately 1% of all social security benefits. The benefits paid for CD were higher than for UC, whereas both tended to decrease from 2010 to 2014. Conclusions In Brazil, IBD frequently causes disability for prolonged periods and contributes to early retirement. Reduction trends may reflect improvements in access to health care and medication. Vocational rehabilitation programs may positively impact social security and the patients’ quality of life.

Suggested Citation

  • Renata S. B. Fróes & Ana Teresa Pugas Carvalho & Antonio Jose V. Carneiro & Adriana Maria Hilu Barros Moreira & Jessica P. L. Moreira & Ronir R. Luiz & Heitor S. de Souza, 2018. "The socio-economic impact of work disability due to inflammatory bowel disease in Brazil," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(3), pages 463-470, April.
  • Handle: RePEc:spr:eujhec:v:19:y:2018:i:3:d:10.1007_s10198-017-0896-4
    DOI: 10.1007/s10198-017-0896-4
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s10198-017-0896-4
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s10198-017-0896-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Mandel Michael & Anita Bálint & Barbara Lovász & László Gulácsi & Bálint Strbák & Petra Golovics & Klaudia Farkas & Zsuzsanna Kürti & Blanka Szilágyi & Anna Mohás & Tamás Molnár & Péter Lakatos, 2014. "Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(1), pages 121-128, May.
    2. Michael Mandel & Anita Bálint & Barbara Lovász & László Gulácsi & Bálint Strbák & Petra Golovics & Klaudia Farkas & Zsuzsanna Kürti & Blanka Szilágyi & Anna Mohás & Tamás Molnár & Péter Lakatos, 2014. "Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(1), pages 129-129, May.
    3. Mathias Lidgren & Nils Wilking & Bengt Jönsson, 2007. "Cost of breast cancer in Sweden in 2002," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(1), pages 5-15, March.
    4. Renee Stark & Hans-Helmut König & Reiner Leidl, 2006. "Costs of Inflammatory Bowel Disease in Germany," PharmacoEconomics, Springer, vol. 24(8), pages 797-814, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. João Martins de Mello-Neto & Jessica Gomes Rodrigues Nunes & Santosh Kumar Tadakamadla & Carlos Marcelo da Silva Figueredo, 2021. "Immunological Traits of Patients with Coexistent Inflammatory Bowel Disease and Periodontal Disease: A Systematic Review," IJERPH, MDPI, vol. 18(17), pages 1-12, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mennini, Francesco Saverio & Gitto, Lara, 2022. "Approaches to Estimating Indirect Costs in Healthcare: Motivations for Choice," MPRA Paper 112129, University Library of Munich, Germany.
    2. Takahiro Mori & Tomohisa Nagata & Masako Nagata & Kiminori Odagami & Koji Mori, 2022. "Perceived Supervisor Support for Health Affects Presenteeism: A Cross-Sectional Study," IJERPH, MDPI, vol. 19(7), pages 1-10, April.
    3. Stijn Baert, 2016. "Wage subsidies and hiring chances for the disabled: some causal evidence," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 71-86, January.
    4. Attila J. Pulay & István Bitter & Szilvia Papp & László Gulácsi & Márta Péntek & Valentin Brodszky & Noémi V. Hevér & Fanni Rencz & Petra Baji, 2017. "Exploring the Relationship between Quality of Life (EQ-5D) and Clinical Measures in Adult Attention Deficit Hyperactivity Disorder (ADHD)," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 12(2), pages 409-424, June.
    5. Mirthe E van der Valk & Marie-Josée J Mangen & Mirjam Severs & Mike van der Have & Gerard Dijkstra & Ad A van Bodegraven & Herma H Fidder & Dirk J de Jong & C Janneke van der Woude & Mariëlle J L Romb, 2016. "Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up," PLOS ONE, Public Library of Science, vol. 11(4), pages 1-11, April.
    6. Przemysław Holko & Paweł Kawalec & Magdalena Sajak-Szczerba & Luisa Avedano & Małgorzata Mossakowska, 2023. "Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(7), pages 1073-1083, September.
    7. Juan Oliva-Moreno, 2012. "Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain’s Economy?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(5), pages 605-614, October.
    8. Marina Kostić & Ljiljan Djakovic & Raša Šujić & Brian Godman & Slobodan M. Janković, 2017. "Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications," Applied Health Economics and Health Policy, Springer, vol. 15(1), pages 85-93, February.
    9. Anne Prenzler & Bernd Bokemeyer & J.-Matthias Schulenburg & Thomas Mittendorf, 2011. "Health care costs and their predictors of inflammatory bowel diseases in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(3), pages 273-283, June.
    10. Steven Broekx & Elly Hond & Rudi Torfs & Anne Remacle & Raf Mertens & Thomas D’Hooghe & Patrick Neven & Marie-Rose Christiaens & Steven Simoens, 2011. "The costs of breast cancer prior to and following diagnosis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(4), pages 311-317, August.
    11. Przemysław Holko & Paweł Kawalec & Małgorzata Mossakowska & Andrzej Pilc, 2016. "Health-Related Quality of Life Impairment and Indirect Cost of Crohn’s Disease: A Self-Report Study in Poland," PLOS ONE, Public Library of Science, vol. 11(12), pages 1-21, December.
    12. Andersen, Signe Hald, 2010. "The cost of sickness: On the effect of the duration of sick leave on post-sick leave earnings," Social Science & Medicine, Elsevier, vol. 70(10), pages 1581-1589, May.
    13. David Scheller‐Kreinsen & on behalf of the EuroDRG group, 2012. "How Well Do Diagnosis‐Related Group Systems Group Breast Cancer Surgery Patients?—Evidence From 10 European Countries," Health Economics, John Wiley & Sons, Ltd., vol. 21(S2), pages 41-54, August.
    14. Lisa Ericson & Lennart Bergfeldt & Ingela Björholt, 2011. "Atrial fibrillation: the cost of illness in Sweden," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(5), pages 479-487, October.

    More about this item

    Keywords

    Inflammatory bowel diseases; Work disability; Crohn’s disease; Ulcerative colitis; Indirect costs; Productivity loss;
    All these keywords.

    JEL classification:

    • I - Health, Education, and Welfare
    • I1 - Health, Education, and Welfare - - Health
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:19:y:2018:i:3:d:10.1007_s10198-017-0896-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.